I think having read a few of the phage articles I can see Recce has a clear advantage there at least. Phage is very specific, very time consuming and has to be tailored to each bacteria being targetted. Recce 327 however doesnt care what the bacteria is it kills them all including gram negative apparently. No special personalisation required just the one same bottle whatever the target it seems. And apparently ingredients are cheap and plentiful and patented.
My questions would be firstly can they really do what they c laim and if so why is it not worth 10 times current value. Secondly what effect does the bacteria have when it all explodes within the body and released the toxins or whatever are contained. Does that bring it's own set of problems we havent heard about yet?
Ann: Corporate Presentation - December 2019, page-25
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
63.5¢ |
Change
-0.035(5.22%) |
Mkt cap ! $130.5M | |||
| Open | High | Low | Value | Volume |
| 67.0¢ | 67.0¢ | 63.5¢ | $32.42K | 49.54K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 16843 | 63.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 65.0¢ | 20000 | 1 |
View Market Depth
| Last trade - 14.21pm 29/04/2024 (20 minute delay) ? |
|
|||||
|
Last
63.5¢ |
Change
-0.035 ( 3.79 %) |
||||
| Open | High | Low | Volume | ||
| 65.5¢ | 65.5¢ | 63.5¢ | 11960 | ||
| Last updated 13.45pm 29/04/2024 ? | |||||
| RCE (ASX) Chart |